ATE296094T1 - Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen - Google Patents

Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Info

Publication number
ATE296094T1
ATE296094T1 AT02747613T AT02747613T ATE296094T1 AT E296094 T1 ATE296094 T1 AT E296094T1 AT 02747613 T AT02747613 T AT 02747613T AT 02747613 T AT02747613 T AT 02747613T AT E296094 T1 ATE296094 T1 AT E296094T1
Authority
AT
Austria
Prior art keywords
treatment
infections
nailbed
nitrogen monoxide
forming compositions
Prior art date
Application number
AT02747613T
Other languages
English (en)
Inventor
Nigel Benjamin
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of ATE296094T1 publication Critical patent/ATE296094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT02747613T 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen ATE296094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (1)

Publication Number Publication Date
ATE296094T1 true ATE296094T1 (de) 2005-06-15

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747613T ATE296094T1 (de) 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Country Status (23)

Country Link
US (2) US20050037093A1 (de)
EP (1) EP1411908B1 (de)
JP (1) JP2005501069A (de)
KR (1) KR20040031780A (de)
CN (1) CN1321633C (de)
AT (1) ATE296094T1 (de)
AU (1) AU2002318001B2 (de)
BR (1) BR0211390A (de)
CA (1) CA2453243C (de)
DE (1) DE60204322T2 (de)
ES (1) ES2242042T3 (de)
GB (1) GB0119011D0 (de)
HR (1) HRP20040059B1 (de)
HU (1) HUP0401190A3 (de)
IL (2) IL159724A0 (de)
MX (1) MXPA04000670A (de)
NO (1) NO20040258L (de)
NZ (1) NZ530577A (de)
PL (1) PL213555B1 (de)
PT (1) PT1411908E (de)
RU (1) RU2298403C2 (de)
WO (1) WO2003013489A1 (de)
ZA (1) ZA200400491B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
JP5564157B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 心臓血管状態の処置のための亜硝酸塩の使用方法
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
DK1871433T3 (da) * 2005-03-24 2009-08-10 Nolabs Ab Kosmetisk behandling med nitrogenoxid, anordning til udförelse af denne behandling samt fremstillingsproces dertil
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
AU2006249323B2 (en) 2005-05-27 2012-08-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
CN101939014B (zh) 2007-11-15 2016-04-27 路易斯安那州大学及农业和机械学院管理委员会 亚硝酸盐在慢性缺血中的应用
US20090196930A1 (en) * 2007-12-27 2009-08-06 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide -donating compounds and uses thereof
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
WO2010048724A1 (en) * 2008-10-30 2010-05-06 Chris Miller Nitric oxide-releasing dressings
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
BR112012008508A2 (pt) * 2009-10-13 2017-06-13 Novan Inc revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
CA2777066C (en) * 2009-10-14 2020-02-18 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
EP2575829A4 (de) * 2010-06-07 2014-04-30 Topical Pharma Ab Kit zur behandlung von onychomykose durch stickoxid
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
EP2729131B1 (de) 2011-07-05 2020-04-15 Novan, Inc. Topische zusammensetzungen
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
WO2013026000A1 (en) * 2011-08-17 2013-02-21 Board Of Regents, The University Of Texas System Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system
US11077194B2 (en) 2012-03-14 2021-08-03 Novan, Inc. Nitric oxide releasing pharmaceutical compositions
ES2741146T3 (es) 2013-02-20 2020-02-10 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Formulaciones farmacéuticas de nitrio y sus usos
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
US12233289B2 (en) 2013-08-01 2025-02-25 Olaplex, Inc. Methods for fixing hair and skin
EP3030266B1 (de) 2013-08-08 2020-10-28 Novan Inc. Topische zusammensetzungen und verfahren zur verwendung davon
CA2946828A1 (en) 2014-03-14 2015-09-17 Nitric Solutions, Inc. Treating diseases using nitric oxide releasing solutions
AU2015258904A1 (en) 2014-05-16 2016-11-17 Liqwd, Inc. Keratin treatment formulations and methods
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
US10322081B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3177262A4 (de) 2014-08-08 2018-04-18 Novan Inc. Topische emulsionen
WO2016172708A1 (en) 2015-04-24 2016-10-27 Liqwd, Inc. Methods for treating relaxed hair
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
EP3423100A4 (de) 2016-03-02 2019-10-16 Novan, Inc. Zusammensetzungen zur behandlung von entzündungen und verfahren zur behandlung davon
WO2017180822A1 (en) 2016-04-13 2017-10-19 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
US11534382B2 (en) 2017-06-19 2022-12-27 Novan, Inc. Topical compositions and methods of using the same
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
WO2019175674A2 (en) 2018-03-13 2019-09-19 Regev Gilly Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
EP3980032A1 (de) 2019-06-04 2022-04-13 Thirty Respiratory Limited Verfahren und zusammensetzungen zur erzeugung von stickoxid und verwendungen davon zur abgabe von stickoxid über die atemwege
GB2599576B (en) 2019-06-04 2023-09-13 Thirty Holdings Ltd Methods and compositions for generating nitric oxide and uses thereof
EP4138795A1 (de) 2020-04-23 2023-03-01 Thirty Respiratory Limited Stickoxid oder stickoxid freisetzende zusammensetzungen zur verwendung bei der behandlung von sars-cov und sars-cov-2
GB2610721B (en) 2020-04-23 2024-07-31 Thirty Respiratory Ltd Compositions for treating and combatting tuberculosis
AU2021307675A1 (en) * 2020-07-16 2023-02-16 Sanotize Research And Development Corp. Methods of treating conditions responsive to nitric oxide therapy
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя
GB2644374A (en) * 2024-09-20 2026-04-08 Thirty Holdings Ltd Compositions and kits for generating nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
PL180769B1 (pl) 1994-02-21 2001-04-30 Univ Aberdeen Postać dawkowana do miejscowego leczenia stanów powodowanych przez drobnoustroje, sposób sterylizacji obiektów i kompozycja sterylizująca
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
IL159724A0 (en) 2004-06-20
CN1564681A (zh) 2005-01-12
GB0119011D0 (en) 2001-09-26
ZA200400491B (en) 2005-04-22
IL159724A (en) 2006-04-10
WO2003013489A1 (en) 2003-02-20
CN1321633C (zh) 2007-06-20
AU2002318001B2 (en) 2007-02-15
PT1411908E (pt) 2005-08-31
US9381381B2 (en) 2016-07-05
EP1411908B1 (de) 2005-05-25
BR0211390A (pt) 2004-08-17
HRP20040059A2 (en) 2004-08-31
HRP20040059B1 (hr) 2008-05-31
NO20040258L (no) 2004-03-29
JP2005501069A (ja) 2005-01-13
MXPA04000670A (es) 2004-10-27
RU2004101765A (ru) 2005-03-10
CA2453243C (en) 2012-01-03
PL213555B1 (pl) 2013-03-29
HUP0401190A3 (en) 2008-08-28
US20100015253A1 (en) 2010-01-21
ES2242042T3 (es) 2005-11-01
PL366579A1 (en) 2005-02-07
EP1411908A1 (de) 2004-04-28
DE60204322D1 (de) 2005-06-30
NZ530577A (en) 2007-01-26
HUP0401190A2 (hu) 2004-11-29
DE60204322T2 (de) 2006-01-26
KR20040031780A (ko) 2004-04-13
RU2298403C2 (ru) 2007-05-10
US20050037093A1 (en) 2005-02-17
CA2453243A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
DE60204322D1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
TW200510416A (en) P38 inhibitors and methods of use thereof
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
NO20055741L (no) Nye kjemiske forbindelser
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
MXPA05009014A (es) Antagonistas del receptor ccr-3.
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
CY1108980T1 (el) Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411908

Country of ref document: EP

REN Ceased due to non-payment of the annual fee